Cargando…
A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes
Despite recent progress in the development of hepatitis C virus (HCV) inhibitors, cost-effective antiviral drugs, especially among the patients receiving liver transplantations, are still awaited. Schisandra is a traditional medicinal herb used to treat a range of liver disorders including hepatitis...
Autores principales: | Qian, Xi-Jing, Zhang, Xiao-Lian, Zhao, Ping, Jin, Yong-Sheng, Chen, Hai-Sheng, Xu, Qing-Qiang, Ren, Hao, Zhu, Shi-Ying, Tang, Hai-Lin, Zhu, Yong-Zhe, Qi, Zhong-Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890123/ https://www.ncbi.nlm.nih.gov/pubmed/27252043 http://dx.doi.org/10.1038/srep27268 |
Ejemplares similares
-
Entry inhibitors: New advances in HCV treatment
por: Qian, Xi-Jing, et al.
Publicado: (2016) -
Two New Compounds from Schisandra propinqua var. propinqua
por: Liu, Miao, et al.
Publicado: (2017) -
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
por: Ashfaq, Usman A, et al.
Publicado: (2011) -
Second-order calibration applied to quantification of two active components of Schisandra chinensis in complex matrix
por: Zhang, Xiao-Hua, et al.
Publicado: (2012) -
SEC14L2 enables pan-genotype HCV replication in cell culture
por: Saeed, Mohsan, et al.
Publicado: (2015)